PMS2 and colorectal carcinoma: In their study from 2020, the prospective LS database included 6350 MMR carriers, of which only 407 carried a pathogenic variant in PMS2. They found that PMS2 carriers did not have an increased CRC risk below 50 years, and that the risk was not significantly increased after 50 years [2].